↓ Skip to main content

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus

Overview of attention for article published in Diabetologia, September 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
2 policy sources
patent
3 patents

Citations

dimensions_citation
464 Dimensions

Readers on

mendeley
132 Mendeley
citeulike
1 CiteULike
connotea
1 Connotea
Title
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
Published in
Diabetologia, September 2006
DOI 10.1007/s00125-006-0416-z
Pubmed ID
Authors

I. Raz, M. Hanefeld, L. Xu, C. Caria, D. Williams-Herman, H. Khatami

Mendeley readers

The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 2%
United Kingdom 1 <1%
Peru 1 <1%
Spain 1 <1%
Russia 1 <1%
United States 1 <1%
Netherlands 1 <1%
Unknown 124 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 26 20%
Student > Master 24 18%
Student > Ph. D. Student 15 11%
Student > Bachelor 14 11%
Other 12 9%
Other 41 31%
Readers by discipline Count As %
Medicine and Dentistry 64 48%
Agricultural and Biological Sciences 24 18%
Unspecified 13 10%
Pharmacology, Toxicology and Pharmaceutical Science 11 8%
Biochemistry, Genetics and Molecular Biology 7 5%
Other 13 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2016.
All research outputs
#1,188,927
of 10,048,535 outputs
Outputs from Diabetologia
#638
of 2,768 outputs
Outputs of similar age
#55,515
of 318,108 outputs
Outputs of similar age from Diabetologia
#36
of 61 outputs
Altmetric has tracked 10,048,535 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,768 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.2. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 318,108 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.